Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy Adolescents.
about
Emerging experience with meningococcal serogroup B protein vaccines.Recent Progress in the Prevention of Serogroup B Meningococcal Disease.Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®).Vaccine Potential and Diversity of the Putative Cell Binding Factor (CBF, NMB0345/NEIS1825) Protein of Neisseria meningitidis.Meningococcal serogroup B vaccines: Estimating breadth of coverage.Bivalent rLP2086 Vaccine (Trumenba(®)): A Review in Active Immunization Against Invasive Meningococcal Group B Disease in Individuals Aged 10-25 Years.An Overview of Structural Features of Antibacterial Glycoconjugate Vaccines That Influence Their Immunogenicity.Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1.Breadth and Duration of Meningococcal Serum Bactericidal Activity in Health Care Workers and Microbiologists Immunized with the MenB-FHbp Vaccine.Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine - Advisory Committee on Immunization Practices, 2016.Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines.
P2860
Q30234958-2589D6C1-CEBF-4FAD-893C-20A52D3BF108Q30235040-2727E700-85D2-426E-8564-D20B2D9EE60CQ30248749-363E0561-B6E3-4C4C-924D-683053425227Q36098758-A300F73F-51F8-4258-8120-3F9D35270BB8Q37669413-354DC507-6851-4BB8-A333-D517DC1BFEA9Q38591053-53812FD4-F9A2-4A46-9200-241D96002319Q39093233-BC2CFF3F-BF7C-480E-B5A7-0107A62B8F0DQ40120418-DC2335D5-0ABD-44A5-B97E-7E9FF5A3B73FQ40178578-901D2BCC-93CF-4F1D-865F-229C102F00BAQ40207692-A7A04226-2365-4F74-B92C-F81D8E774880Q54233532-A16EC007-6567-43E4-9247-6CA07205D787
P2860
Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy Adolescents.
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Meningococcal Serogroup B Biva ...... ponses in Healthy Adolescents.
@ast
Meningococcal Serogroup B Biva ...... ponses in Healthy Adolescents.
@en
type
label
Meningococcal Serogroup B Biva ...... ponses in Healthy Adolescents.
@ast
Meningococcal Serogroup B Biva ...... ponses in Healthy Adolescents.
@en
prefLabel
Meningococcal Serogroup B Biva ...... ponses in Healthy Adolescents.
@ast
Meningococcal Serogroup B Biva ...... ponses in Healthy Adolescents.
@en
P2093
P2860
P356
P1476
Meningococcal Serogroup B Biva ...... sponses in Healthy Adolescents
@en
P2093
Carl-Erik Flodmark
Graham Crowther
Jacek Wysocki
Johannes Beeslaar
John L Perez
Joseph Eiden
Kathrin U Jansen
Laura J York
Robert E O'Neill
P2860
P304
P356
10.1093/JPIDS/PIV039
P577
2015-08-04T00:00:00Z